[1]
M. Breccia and G. Alimena, “SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs”, MJHID, vol. 6, no. 1, p. e2014003, Jan. 2014.